Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort

被引:15
作者
Chang, Madeleine [1 ]
Chang, Devon [1 ]
Kodali, Sudha [2 ]
Harrison, Stephen A. [3 ,4 ]
Ghobrial, Mark [2 ]
Alkhouri, Naim [5 ]
Noureddin, Mazen [2 ]
机构
[1] Arnold O Beckman High Sch, Irvine, CA USA
[2] Houston Methodist, Houston, TX USA
[3] Univ Oxford, Radcliffe Dept Med, Oxford, England
[4] Pinnacle Clin Res Ctr, San Antonio, TX USA
[5] Arizona Liver Hlth, Phoenix, AZ USA
关键词
MASH; NASH; Noninvasive Test; Steatosis; LIVER-BIOPSY; TESTS; MANAGEMENT; FIBROSIS;
D O I
10.1016/j.cgh.2024.02.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: In the American Gastroenterological Association/American Association for the Study of Liver Diseases (AGA/AASLD) Clinical Care Pathway, Fibrosis-4 index (FIB-4) is used to stratify patients at risk for metabolic dysfunction-associated steatotic liver disease (MASLD) as low-, indeterminate-, or high-risk for developing advanced liver fi brosis. We assessed the performance of FIB-4 in a general population. METHODS: Using the 2017 to 2020 National Health and Nutrition Examination Surveys dataset, we selected subjects >= 18 years who had FibroScan data. We followed AGA/AASLD guidelines to identify subjects with characteristics that place them at risk for MASLD-associated liver fi brosis. Other causes of liver disease were excluded. Our fi nal cohort had 3741 subjects. We then categorized these subjects based on recommended FIB-4 cutoffs. FibroScan liver stiffness measurement (LSM) served as the outcome measurement. RESULTS: Among the 2776 subjects (74.2%) classified fi ed as low risk by FIB-4, 277 subjects (10%) were not classified fi ed at low risk by LSM, and 75 subjects (2.7%) were classified fi ed as high risk by LSM. Among the 86 subjects classified fi ed as high risk by FIB-4, 68 subjects (79.1%) were not at high risk by LSM, and 54 subjects (62.8%) were at low risk by LSM. Subjects misclassified fi ed by FIB-4 as low risk were older; had a higher body mass index, waist circumference, glycohemoglobin A1c level, alanine transaminase, aspartate transaminase, diastolic blood pressure, controlled attenuation parameter score, white blood cell count, alkaline phosphatase, and fasting glucose level; but had lower high-density lipoprotein, and albumin level (all P < .05). Misclassified fi ed subjects were also more likely to have prediabetes/diabetes. CONCLUSION: Using FIB-4 in the AGA/AASLD guidelines to risk-stratify subjects at risk for MASLD-associated fi brosis results in many subjects being misclassified fi ed into the low- and high-risk categories. Therefore, it may be worthwhile considering caution in interpretation and/or alternative strategies.
引用
收藏
页码:1453 / 1461
页数:9
相关论文
共 21 条
[1]   Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease [J].
Boursier, Jerome ;
Vergniol, Julien ;
Guillet, Anne ;
Hiriart, Jean-Baptiste ;
Lannes, Adrien ;
Le Bail, Brigitte ;
Michalak, Sophie ;
Chermak, Faiza ;
Bertrais, Sandrine ;
Foucher, Juliette ;
Oberti, Frederic ;
Charbonnier, Maude ;
Fouchard-Hubert, Isabelle ;
Rousselet, Marie-Christine ;
Cales, Paul ;
de Ledinghen, Victor .
JOURNAL OF HEPATOLOGY, 2016, 65 (03) :570-578
[2]   Determination of reliability criteria for liver stiffness evaluation by transient elastography [J].
Boursier, Jerome ;
Zarski, Jean-Pierre ;
de Ledinghen, Victor ;
Rousselet, Marie-Christine ;
Sturm, Nathalie ;
Lebail, Brigitte ;
Fouchard-Hubert, Isabelle ;
Gallois, Yves ;
Oberti, Frederic ;
Bertrais, Sandrine ;
Cales, Paul .
HEPATOLOGY, 2013, 57 (03) :1182-1191
[3]   Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease [J].
Castera, Laurent ;
Friedrich-Rust, Mireen ;
Loomba, Rohit .
GASTROENTEROLOGY, 2019, 156 (05) :1264-+
[4]   Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis [J].
Chang, Devon ;
Truong, Emily ;
Mena, Edward A. ;
Pacheco, Fabiana ;
Wong, Micaela ;
Guindi, Maha ;
Todo, Tsuyoshi T. ;
Noureddin, Nabil ;
Ayoub, Walid ;
Yang, Ju Dong ;
Kim, Irene K. ;
Kohli, Anita ;
Alkhouri, Naim ;
Harrison, Stephen ;
Noureddin, Mazen .
HEPATOLOGY, 2023, 77 (02) :546-557
[5]   Pathogenesis of non-alcoholic fatty liver disease [J].
Dowman, J. K. ;
Tomlinson, J. W. ;
Newsome, P. N. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (02) :71-83
[6]   Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease [J].
Eddowes, Peter J. ;
Sasso, Magali ;
Allison, Michael ;
Tsochatzis, Emmanouil ;
Anstee, Quentin M. ;
Sheridan, David ;
Guha, Indra N. ;
Cobbold, Jeremy F. ;
Deeks, Jonathan J. ;
Paradis, Valerie ;
Bedossa, Pierre ;
Newsome, Philip N. .
GASTROENTEROLOGY, 2019, 156 (06) :1717-1730
[7]   Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population [J].
Graupera, Isabel ;
Thiele, Maja ;
Serra-Burriel, Miquel ;
Caballeria, Llorenc ;
Roulot, Dominique ;
Wong, Grace Lai-Hung ;
Fabrellas, Nuria ;
Guha, Indra Neil ;
Arslanow, Anita ;
Exposito, Carmen ;
Hernandez, Rosario ;
Aithal, Guruprasad Padur ;
Galle, Peter R. ;
Pera, Guillem ;
Wong, Vincent Wai-Sun ;
Lammert, Frank ;
Gines, Pere ;
Castera, Laurent ;
Krag, Aleksander .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (11) :2567-+
[8]   NIS2+TM, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study [J].
Harrison, Stephen A. ;
Ratziu, Vlad ;
Magnanensi, Jeremy ;
Hajji, Yacine ;
Deledicque, Sylvie ;
Majd, Zouher ;
Rosenquist, Christian ;
Hum, Dean W. ;
Staels, Bart ;
Anstee, Quentin M. ;
Sanyal, Arun J. .
JOURNAL OF HEPATOLOGY, 2023, 79 (03) :758-767
[9]   Nonalcoholic steatohepatitis: global impact and clinical consequences [J].
Kabarra, Khaled ;
Golabi, Pegah ;
Younossi, Zobair M. .
ENDOCRINE CONNECTIONS, 2021, 10 (10) :R240-R247
[10]   Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease [J].
Kanwal, Fasiha ;
Shubrook, Jay H. ;
Adams, Leon A. ;
Pfotenhauer, Kim ;
Wong, Vincent Wai-Sun ;
Wright, Eugene ;
Abdelmalek, Manal F. ;
Harrison, Stephen A. ;
Loomba, Rohit ;
Mantzoros, Christos S. ;
Bugianesi, Elisabetta ;
Eckel, Robert H. ;
Kaplan, Lee M. ;
El-Serag, Hashem B. ;
Cusi, Kenneth .
GASTROENTEROLOGY, 2021, 161 (05) :1657-1669